Upcoming Meetings: FDA's Circulatory System Devices Panel
This article was originally published in The Gray Sheet
FDA's Circulatory System Devices Panel: Meeting July 15 at 9200 Corporate Blvd., Rockville, Maryland, to discuss a premarket approval application for a pacemaker lead and issues related to a draft guidance for automatic implantable pacer cardioverter defibrillators. The guidance discussion "primarily" will focus on "new suggested labeling changes," FDA says. For more information contact FDA's Ramiah Subramanian, 301/443-8320...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.